SHG · Healthcare

Hinova Pharmaceuticals Inc. A (688302)

Biotechnology

Hinova Pharmaceuticals Inc. A (688302) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $4.03B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 688302

Market cap
$4.03B
P/E ratio
18.00
Gross profit (TTM)
$20.67M
Net margin
0.0%

Hinova Pharmaceuticals Inc. A (688302) — FAQ

What is Hinova Pharmaceuticals Inc. A's market cap?

Hinova Pharmaceuticals Inc. A (688302) has a reported market cap of $4.03B (data as of 2026-03-29).

What is 688302's P/E ratio?

The price-to-earnings (P/E) ratio for Hinova Pharmaceuticals Inc. A (688302) is 18.00 (data as of 2026-03-29).

Does Hinova Pharmaceuticals Inc. A pay a dividend?

Dividend yield is not available in the current snapshot for Hinova Pharmaceuticals Inc. A (688302). Check the MyAverix Finance app for the latest dividend data.

What sector is Hinova Pharmaceuticals Inc. A in?

Hinova Pharmaceuticals Inc. A (688302) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 688302 listed on?

688302 is listed on SHG.

What is Hinova Pharmaceuticals Inc. A's net margin?

Hinova Pharmaceuticals Inc. A (688302) reports a net margin of 0.0% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play